AbbVie is acquiring Capstan Therapeutics, a startup with technology that enables in vivo engineering of immune cells.

Proteins have specific biological functions in cells through conformational changes and interactions. Therefore, precise, in ...

Prostate cancer is one of the most common malignancies in men globally. Hormonal therapies targeting the androgen–androgen ...

Assessing the distribution of a medication in the brain is critical for the treatment of a vast range of neurological ...

Antibiotic efflux pumps are expressed in all microbes, where they serve as crucial gatekeepers in resisting the cellular ...

AbbVie has agreed to buy Capstan Therapeutics for up to $2.1 billion, expanding its pipeline with a potential first-in-class ...

Natural products industry companies share overviews on the latest science on their dietary supplement branded ingredients and ...

CCS Chemistry 2025年第7期上线！本期包括3篇Mini-Review，3篇Communication和19篇Research ...

TAIPEI, Taiwan and SHANGHAI, China and SAN FRANCISCO, CA, USA I July 1, 2025 I HanchorBio Inc. (7827.TWO), a global clinical-stage biotechnology company ...